News

The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...
The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...
Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...
Biocon share price gained 2.5 per cent after reports suggested that the company is planning to file for generic versions of ...
Biocon Ltd. is set to seek regulatory approvals for generic versions of Novo Nordisk's Ozempic and Wegovy, targeting key ...
The Semaglutide market is projected to expand from US$ 27.15 billion in 2024 to US$ 61.7 billion by 2033, with a CAGR of 9.55% from 2025. Driven by r ...